Short Interest in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Decreases By 45.2%

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 119,902 shares, a decrease of 45.2% from the April 30th total of 218,817 shares. Approximately 1.4% of the company’s stock are sold short. Based on an average daily volume of 219,779 shares, the short-interest ratio is currently 0.5 days.

Hedge Funds Weigh In On Baird Medical Investment

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BDMD. Citadel Advisors LLC bought a new position in shares of Baird Medical Investment in the third quarter valued at approximately $99,000. Jane Street Group LLC bought a new position in shares of Baird Medical Investment in the second quarter valued at approximately $142,000. Finally, Geode Capital Management LLC boosted its position in shares of Baird Medical Investment by 59.7% in the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock valued at $93,000 after acquiring an additional 9,511 shares during the period. Institutional investors own 19.78% of the company’s stock.

Baird Medical Investment Price Performance

NASDAQ:BDMD traded down $0.12 on Tuesday, reaching $1.34. 178,943 shares of the company’s stock were exchanged, compared to its average volume of 1,322,580. Baird Medical Investment has a 52 week low of $0.76 and a 52 week high of $7.26. The stock has a fifty day simple moving average of $1.78 and a 200-day simple moving average of $1.61.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Weiss Ratings lowered shares of Baird Medical Investment from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, May 8th. Wall Street Zen upgraded shares of Baird Medical Investment to a “hold” rating in a research report on Saturday, March 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.